BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 132332)

  • 1. Plasma growth hormone concentrations in Huntington's chorea.
    Phillipson OT; Bird ED
    Clin Sci Mol Med; 1976 Jun; 50(6):551-4. PubMed ID: 132332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma glucose, non-esterified fatty acids and amino acids in Huntington's chorea.
    Phillipson OT; Bird ED
    Clin Sci Mol Med; 1977 Mar; 52(3):311-8. PubMed ID: 139225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exaggerated growth hormone response to arginine infusion in Huntington's disease.
    Leopold NA; Podolsky S
    J Clin Endocrinol Metab; 1975 Jul; 41(1):160-3. PubMed ID: 125287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fatty acid patterns and glucose tolerance in Huntington's chorea (author's transl)].
    Schubotz R; Hausmann L; Kaffarnik H; Zehner J; Oepen H
    Res Exp Med (Berl); 1976 Jul; 167(3):203-15. PubMed ID: 136033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease.
    Podolsky S; Leopold NA
    Gerontology; 1977; 23(1):55-63. PubMed ID: 136379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
    Caraceni T; Panerai AE; Paratl EA; Cocchi D; Müller EE
    J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.
    Durso R; Tamminga CA; Ruggeri S; Denaro A; Kuo S; Chase TN
    J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1134-7. PubMed ID: 6229607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered growth hormone release in Huntington's chorea.
    Keogh HJ; Johnson RH; Nanda RN; Sulaiman WR
    J Neurol Neurosurg Psychiatry; 1976 Mar; 39(3):244-8. PubMed ID: 132511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
    Destée A; Petit H; Fossati P; Warot P
    Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
    [No Abstract]   [Full Text] [Related]  

  • 10. Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea.
    Murri L; Iudice A; Muratorio A; Polleri A; Barreca T; Murialdo G
    Eur Neurol; 1980; 19(3):198-206. PubMed ID: 6446454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Metabolic Study of Huntington's Disease.
    Nambron R; Silajdžić E; Kalliolia E; Ottolenghi C; Hindmarsh P; Hill NR; Costelloe SJ; Martin NG; Positano V; Watt HC; Frost C; Björkqvist M; Warner TT
    PLoS One; 2016; 11(1):e0146480. PubMed ID: 26744893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenic amines in the hypothalamus: effect of L-DOPA on human growth hormone levels in patients with Huntington's chorea.
    Podolsky S; Leopold NA
    Prog Brain Res; 1973; 39():225-35. PubMed ID: 4275115
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
    Chalmers RJ; Johnson RH; Keogh HJ; Nanda RN
    J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and prolactin release in Huntington's chorea.
    Chalmers RJ; Johnson RH; Nanda RN
    Lancet; 1977 Oct; 2(8042):824. PubMed ID: 71631
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
    Podolsky S; Leopold NA
    J Clin Endocrinol Metab; 1974 Jul; 39(1):36-9. PubMed ID: 4276011
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington's disease patients.
    Russo CV; Salvatore E; Saccà F; Tucci T; Rinaldi C; Sorrentino P; Massarelli M; Rossi F; Savastano S; Di Maio L; Filla A; Colao A; De Michele G
    J Huntingtons Dis; 2013; 2(4):501-7. PubMed ID: 25062734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of hypothalamic function in Huntington's chorea.
    Lavin PJ; Bone I; Sheridan P
    J Neurol Neurosurg Psychiatry; 1981 May; 44(5):414-8. PubMed ID: 6455503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol, glucagon and growth hormone responses to oral glucose in non-insulin-dependent diabetes in the young.
    Jialal I; Joubert SM
    S Afr Med J; 1982 Oct; 62(16):549-52. PubMed ID: 6750813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.